These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9635523)

  • 21. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas.
    Rigg A; Cunningham D; Gore M; Hill M; O'Brien M; Nicolson M; Chang J; Watson M; Norman A; Hill A; Oates J; Moore H; Ross P
    Br J Cancer; 1997; 75(1):101-5. PubMed ID: 9000605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.
    Crown J; Casper ES; Botet J; Murray P; Kelsen DP
    J Clin Oncol; 1991 Sep; 9(9):1682-6. PubMed ID: 1875224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboplatin plus 5-fluorouracil and leucovorin in previously treated patients with metastatic breast cancer.
    Fiorentino MV; Brandes A
    Ann Oncol; 1992 Aug; 3 Suppl 3():28-32. PubMed ID: 1390314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413).
    Macdonald JS; Jacobson JL; Modiano M; Moore DF; Gandara DR; Schroder LE; Chapman RA
    Invest New Drugs; 2000 Aug; 18(3):269-73. PubMed ID: 10958597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
    Whittington R; Neuberg D; Tester WJ; Benson AB; Haller DG
    J Clin Oncol; 1995 Jan; 13(1):227-32. PubMed ID: 7799024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
    Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.
    Patt YZ; Jones DV; Hoque A; Lozano R; Markowitz A; Raijman I; Lynch P; Charnsangavej C
    J Clin Oncol; 1996 Aug; 14(8):2311-5. PubMed ID: 8708722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of oral L-leucovorin, 120-hour fluorouracil infusion and carboplatin in advanced pancreatic cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Tumori; 1996; 82(6):573-5. PubMed ID: 9061066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for pancreatic carcinoma.
    Ahlgren JD
    Cancer; 1996 Aug; 78(3 Suppl):654-63. PubMed ID: 8681304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma.
    Yashima Y; Sato S; Kawai T; Sugimoto T; Sato T; Kanda M; Obi S
    Hepatol Int; 2015 Jan; 9(1):142-8. PubMed ID: 25788388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-arterial chemotherapy for unresectable pancreatic cancer.
    Cantore M; Pederzoli P; Cornalba G; Fiorentini G; Guadagni S; Miserocchi L; Frassoldati A; Ceravolo C; Smerieri F; Muchmore JH
    Ann Oncol; 2000 May; 11(5):569-73. PubMed ID: 10907950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study.
    Kajanti M; Pyrhönen S
    Am J Clin Oncol; 1994 Jun; 17(3):223-6. PubMed ID: 8192106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil.
    Yürek S; Riess H; Kreher S; Dörken B; Salama A
    Transfus Med; 2010 Aug; 20(4):265-8. PubMed ID: 20456688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonogenic survival studies of human colon tumor cell lines in vitro: combined hyperthermia, 5-fluorouracil/leucovorin, carboplatin and tumor necrosis factor.
    Klostergaard J; Leroux ME; Tomasovic SP
    Radiat Res; 1995 Jan; 141(1):44-8. PubMed ID: 7997513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy and multimodality management of cholangiocarcinoma.
    Urego M; Flickinger JC; Carr BI
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):121-6. PubMed ID: 10219804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
    Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
    Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II survival comparison of patients with adenocarcinoma of the pancreas treated with 5-fluorouracil and calcium leucovorin versus a matched tumor registry control population.
    Weinerman BH; MacCormick RE
    Am J Clin Oncol; 1994 Dec; 17(6):467-9. PubMed ID: 7977161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.